North America Contraceptives Market By Drug Type - Contraceptive Pills, Topical Contraceptives, Contraceptive Injectable, Others (contraceptive Gels, Jellies And Creams), By Medical Devices - Male Contraceptive Devices (Condoms), Female Contraceptive Devices (female Condoms, Intrauterine Devices, Contraceptive Sponges, Contraceptive Diaphragms, Contraceptive Patches, Subdermal Contraceptive Implants And Non-surgical Permanent Contraceptive Devices), By End Users – Hospitals, Home Care, Clinics And Ambulatory Surgical Centres By Region – Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

North America Contraceptives Market By Drug Type - Contraceptive Pills, Topical Contraceptives, Contraceptive Injectable, Others (contraceptive Gels, Jellies And Creams), By Medical Devices - Male Contraceptive Devices (Condoms), Female Contraceptive Devices (female Condoms, Intrauterine Devices, Contraceptive Sponges, Contraceptive Diaphragms, Contraceptive Patches, Subdermal Contraceptive Implants And Non-surgical Permanent Contraceptive Devices), By End Users – Hospitals, Home Care, Clinics And Ambulatory Surgical Centres By Region – Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

ID: 1229 | Pages: 136 | April 2018 | Region: North America


Overview of the Market:
The North America Contraceptives Market was worth $ 7.33 billion in 2018 and estimated to reach $ 9.99 billion by the end of 2023 with a growing potential of 6.40%.

Contraception methods can be permanent or temporary that are available for both men and women. Permanent methods include tubal occlusion or hysteroscopy and vasectomy. Temporary methods are of two types i.e., hormonal and non-hormonal. Hormonal methods include contraceptive transdermal patches, hormonal IUDs, oral contraceptive pills, vaginal implants, and vaginal rings. Non-hormonal methods include diaphragms, withdrawal methods, sponges, condoms, non-hormonal IUDs and cervical caps. Condoms, sponges, diaphragms, and cervical caps are also referred to as barrier contraception methods.

The North America market is mainly driven by increasing development of effective female contraceptive devices and drugs, technological advancements, increasing initiatives from government and NGO to promote contraceptives. Restraints that are hampering the growth of the market are the side effects associated with the use of contraceptive devices and drugs, rising prevalence of infertility.

Based on drug type the market is segmented into Contraceptive pills, Topical contraceptives, Contraceptive injectable, others (contraceptive gels, jellies and creams).

Based on medical devices the market is segmented into Male contraceptive devices (Condoms), Female contraceptive devices. Female contraceptive devices are further classified into female condoms, intrauterine devices (Hormonal IUD’s, Copper IUD’s), contraceptive sponges, contraceptive diaphragms, contraceptive patches, subdermal contraceptive implants and non-surgical permanent contraceptive devices.

Geographical Analysis: 
Based on end users the market is segmented into Hospitals, Home care, Clinics and Ambulatory Surgical Centres. The North America market is analyzed under various regions namely U.S, Canada.

Key Players in this Market: 
Some of the key players that are dominating the North America contraceptives market are Bayer HealthCare AG, Teva Pharmaceutical Industries Limited, Medisafe Distribution Inc, Pace Pharmaceuticals Inc., Medicines360, Church & Dwight, Co., Inc., Actavis, Inc., CooperSurgical, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Mayer Laboratories, Inc., and Pfizer, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Drug type                              

                                5.1.1 Contraceptive pills               

                                5.1.2 Topical contraceptives       

                                5.1.3 Contraceptive injectable   

                                5.1.4 Others (contraceptive gels, jellies and creams)        

                5.2 By Medical Devices                 

                                5.2.1 Male contraceptive devices             

                                5.2.2 Female contraceptive devices        

                                                5.2.2.1 Female condoms

                                                5.2.2.2 Intrauterine devices

                                                5.2.2.3 Contraceptive sponges

                                                5.2.2.4 Contraceptive diaphragms

                                                5.2.2.5 Contraceptive patches

                                                5.2.2.6 Subdermal contraceptive implants

                                                5.2.2.7 Non-surgical permanent contraceptive devices

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 United States            

                                6.3 Canada         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Bayer HealthCare AG                             

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Teva Pharmaceutical Industries Limited                         

                8.3 Medisafe Distribution Inc                     

                8.4 Pace Pharmaceuticals Inc                     

                8.5 Medicines360                            

                8.6 Church & Dwight, Co., Inc.                   

                8.7 Actavis, Inc                 

                8.8 CooperSurgical                         

                8.9 Merck & Co., Inc                       

                8.10 Reckitt Benckiser plc                            

                8.11 Mayer Laboratories, Inc                      

                8.12 Pfizer, Inc                  

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10. Market outlook and Investment oppurtunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. North America Contraceptives Market By Drug type, From 2018-2023 ( USD Billion )
  2. North America Contraceptive pills Market By Region, From 2018-2023 ( USD Billion )
  3. North America Topical contraceptives Market By Region, From 2018-2023 ( USD Billion )
  4. North America Contraceptive injectable Market By Region, From 2018-2023 ( USD Billion )
  5. North America Contraceptives Market By Medical Devices, From 2018-2023 ( USD Billion )
  6. North America Male Contraceptive devices Market By Region, From 2018-2023 ( USD Billion )
  7. North America Female Contraceptive devices Market By Region, From 2018-2023 ( USD Billion )
  8. North America Contraceptives Market By End users, From 2018-2023 ( USD Billion )
  9. North America Hospitals Market By Region, From 2018-2023 ( USD Billion )
  10. North America Home care Market By Region, From 2018-2023 ( USD Billion )
  11. North America Clinics Market By Region, From 2018-2023 ( USD Billion )
  12. North America Ambulatory Surgical Centres Market By Region, From 2018-2023 ( USD Billion )
  13. United States Contraceptives Market By Drug type, From 2018-2023 ( USD Billion )
  14. United States Contraceptives Market By Medical Devices, From 2018-2023 ( USD Billion )
  15. United States Contraceptives Market By End users, From 2018-2023 ( USD Billion )
  16. Canada Contraceptives Market By Drug type, From 2018-2023 ( USD Billion )
  17. Canada Contraceptives Market By Medical Devices, From 2018-2023 ( USD Billion )
  18. Canada Contraceptives Market By End users, From 2018-2023 ( USD Billion )
  19. North America Contraceptives Market Market By Female contraceptive Devices, From 2018-2023 ( USD Billion )
  20. North America female condoms Market By Region, From 2018-2023 ( USD Billion )
  21. North America intrauterine devices Market By Region, From 2018-2023 ( USD Billion )
  22. North America contraceptive sponges Market By Region, From 2018-2023 ( USD Billion )
  23. North America contraceptive diaphragms Market By Region, From 2018-2023 ( USD Billion )
  24. North America contraceptive patches Market By Region, From 2018-2023 ( USD Billion )
  25. North America subdermal contraceptive implants Market By Region, From 2018-2023 ( USD Billion )
  26. North America non-surgical permanent contraceptive devices Market By Region, From 2018-2023 ( USD Billion )
  27. United States Contraceptives Market Market By Female contraceptive Devices, From 2018-2023 ( USD Billion )
  28. Canada Contraceptives Market Market By Female contraceptive Devices, From 2018-2023 ( USD Billion )
  29. North America Contraceptives Market Market By Female contraceptive Devices, From 2018-2023 ( USD Billion )
  30. North America female condoms Market By Region, From 2018-2023 ( USD Billion )
  31. North America intrauterine devices Market By Region, From 2018-2023 ( USD Billion )
  32. North America contraceptive sponges Market By Region, From 2018-2023 ( USD Billion )
  33. North America contraceptive diaphragms Market By Region, From 2018-2023 ( USD Billion )
  34. North America contraceptive patches Market By Region, From 2018-2023 ( USD Billion )
  35. North America subdermal contraceptive implants Market By Region, From 2018-2023 ( USD Billion )
  36. North America non-surgical permanent contraceptive devices Market By Region, From 2018-2023 ( USD Billion )
  37. United States Contraceptives Market Market By Female contraceptive Devices, From 2018-2023 ( USD Billion )
  38. Canada Contraceptives Market Market By Female contraceptive Devices, From 2018-2023 ( USD Billion )
  39. North America Contraceptives Market Market By Intrauterine devices, From 2018-2023 ( USD Billion )
  40. North America Hormonal IUD's Market By Region, From 2018-2023 ( USD Billion )
  41. United States Contraceptives Market Market By Intrauterine devices, From 2018-2023 ( USD Billion )
  42. Canada Contraceptives Market Market By Intrauterine devices, From 2018-2023 ( USD Billion )
The Anti-neoplastic Market Is Predicted To Reach USD Xx Billion With A CAGR Of Xx% According To Market Data Forecast Report....
Middle East and Africa Anti-neoplastic Agents Market by product type ( personalised medicine, biological agents and chemotherapeutic agents) , by end user( hospitals, clinics, cancer rehabilitation centres and ambul...
Middle East and Africa Anti-neoplastic Agents Market by product type ( personalised medicine, biological agents and chemotherapeutic agents) , by end user( hospitals, clinics, cancer rehabilitation centres and ambul...
Latin America Anti-neoplastic Agents Market By Product Type ( Personalised Medicine, Biological Agents And Chemotherapeutic Agents) , By End User( Hospitals, Clinics, Cancer Rehabilitation Centres And Ambulatory Sur...
Asia Pacific Anti-neoplastic Agents Market By Product Type ( Personalised Medicine, Biological Agents And Chemotherapeutic Agents) , By End User( Hospitals, Clinics, Cancer Rehabilitation Centres And Ambulatory Surg...
Europe Anti-neoplastic Agents Market By Product Type ( Personalised Medicine, Biological Agents And Chemotherapeutic Agents) , By End User( Hospitals, Clinics, Cancer Rehabilitation Centres And Ambulatory Surgical C...
North America Anti-neoplastic Agents Market By Product Type ( Personalised Medicine, Biological Agents And Chemotherapeutic Agents) , By End User( Hospitals, Clinics, Cancer Rehabilitation Centres And Ambulatory Sur...
Anti-neoplastic Agents Market - Segmented By Product Type, End-User, And Region - Global Growth, Trends, And Forecast -2023...
Middle East And Africa Bone Densitometer Devices Market By Specialty (Cardiology, Dermatology, Neurology, Orthopedics, Emergency Care, Gynecology), By Services (Tele-Consultation, Tele-Monitoring, Tele-Education, ...
Latin America Bone Densitometer Devices Market By Specialty (Cardiology, Dermatology, Neurology, Orthopedics, Emergency Care, Gynecology), By Services (Tele-Consultation, Tele-Monitoring, Tele-Education, Tele-Surg...
Europe Bone Densitometer Devices Market By Specialty (Cardiology, Dermatology, Neurology, Orthopedics, Emergency Care, Gynecology), By Services (Tele-Consultation, Tele-Monitoring, Tele-Education, Tele-Surgery, Te...
North America Bone Densitometer Devices Market By Specialty (Cardiology, Dermatology, Neurology, Orthopedics, Emergency Care, Gynecology), By Services (Tele-Consultation, Tele-Monitoring, Tele-Education, Tele-Surg...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.